LXRX (Lexicon Pharmaceuticals) Short Percentage of Float


LXRX Lexicon Pharmaceuticals Inc LXRX
57 GF Score
Price $2.64
GF Value $8.32
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Lexicon Pharmaceuticals Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LXRX vs CGEM, WVE, CRVS: Short Percentage of Float Comparison

For the Biotechnology subindustry, Lexicon Pharmaceuticals's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexicon Pharmaceuticals Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lexicon Pharmaceuticals's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Lexicon Pharmaceuticals's Short Percentage of Float falls into.


LXRX
57GF Score
Lexicon Pharmaceuticals Inc LXRX
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lexicon Pharmaceuticals (LXRX) Overvalued in 2026?

Based on GuruFocus' analysis, Lexicon Pharmaceuticals stock appears to be undervalued. The current stock price of $2.64 is trading 68.3% below its estimated GF Value™ of $8.32. GuruFocus considers Lexicon Pharmaceuticals to be Possible Value Trap.

Key valuation signals for LXRX:

  • Short Percentage of Float:
  • GF Value™: $8.32 vs. price of $2.64 (68.3% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the LXRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lexicon Pharmaceuticals Business Description

Address 2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
57GF Score

Get the complete analysis for LXRX

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.64
Price
$8.32
GF Value